COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,755 Articles (22,502 medRxiv, 8,253 bioRxiv)

Most recent first Previous |  Page 1759: Articles 17581-17590  | Next

Symptom reporting in over 1 million people: community detection of COVID-19
Joshua Elliott, Matthew Whitaker, Barbara Bodinier, Steven Riley, Helen Ward, Graham Cooke, Ara Darzi, Marc Chadeau-Hyam, Paul Elliott
10.1101/2021.02.10.21251480 — Posted: 2021-02-12
A participatory modelling approach for investigating the spread of COVID-19 in countries of the Eastern Mediterranean Region to support public health decision-making
Keyrellous Adib, Penelope A. Hancock, Aysel Rahimli, Bridget Mugisa, Fayez Abdulrazeq, Noha Farag, Ricardo Aguas, Lisa White, Rana Hajjeh, Lubna Al Ariqi, Pierre Nabeth
10.1101/2021.02.10.21251474 — Posted: 2021-02-12
Correcting excess mortality for pandemic-associated population decreases
Jeremy Samuel Faust, Chengan Du, Shu-Xia Li, Zhenqiu Lin, Harlan M. Krumholz
10.1101/2021.02.10.21251461 — Posted: 2021-02-12
COVID-19 and Influenza: Vaccination Before and During the Pandemic among the Lebanese Adult Population
Anthony Elia, Nedal Taha, Sima Tokajian
10.1101/2021.02.10.21251392 — Posted: 2021-02-12
Safety and efficacy of the ChAdOx1 nCoV-19 (AZD1222) Covid-19 vaccine against the B.1.351 variant in South Africa
Shabir A. Madhi, Vicky Baillie, Clare L. Cutland, Merryn Voysey, Anthonet L. Koen, Lee Fairlie, Sherman D. Padayachee, Keertan Dheda, Shaun L. Barnabas, Qasim Ebrahim Bhorat, Carmen Briner, Gaurav Kwatra, NGS-SA, Wits-VIDA COVID team, Khatija Ahmed, Parvinder Aley, Sutika Bhikha, Jinal N. Bhiman, As’ad Ebrahim Bhorat, Jeanine du Plessis, Aliasgar Esmail, Marisa Groenewald, Elizea Horne, Shi-Hsia Hwa, Aylin Jose, Teresa Lambe, Matt Laubscher, Mookho Malahleha, Masebole Masenya, Mduduzi Masilela, Shakeel McKenzie, Kgaogelo Molapo, Andrew Moultrie, Suzette Oelofse, Faeezah Patel, Sureshnee Pillay, Sarah Rhead, Hylton Rodel, Lindie Rossouw, Carol Taoushanis, Houriiyah Tegally, Asha Thombrayil, Samuel van Eck, Constantinos Kurt Wibmer, Nicholas M. Durham, Elizabeth J Kelly, Tonya L Villafana, Sarah Gilbert, Andrew J Pollard, Tulio de Oliveira, Penny L. Moore, Alex Sigal, Alane Izu
10.1101/2021.02.10.21251247 — Posted: 2021-02-12 Discussion: Onsite | Offsite
Response to Whole-Lung Low-Dose Radiation Therapy (LD-RT) Predicts Freedom from Intubation in Patients Receiving Dexamethasone and/or Remdesevir for COVID-19-Related Acute Respiratory Distress Syndrome (ARDS)
Clayton B. Hess, Tony Y. Eng, Tahseen H. Nasti, Vishal R. Dhere, Troy J. Kleber, Jeffrey M. Switchenko, Brent D. Weinberg, Nadine Rouphael, Sibo Tian, Soumon Rudra, Luisa S. Taverna, Alvaro Perez, Rafi Ahmed, Mohammad K. Khan
10.1101/2021.02.10.21251242 — Posted: 2021-02-12
Seroprevalence of SARS-CoV-2, symptom profiles and seroneutralization during the first COVID-19 wave in a suburban area, France
Anne Gégout petit, Hélène Jeulin, Karine Legrand, Agathe Bochnakian, Pierre Vallois, Evelyne Schvoerer, Francis Guillemin
10.1101/2021.02.10.21250862 — Posted: 2021-02-12
Quantifying the preventive effect of wearing face masks
Tom Britton
10.1101/2021.02.09.21251448 — Posted: 2021-02-12
Note: Forecasting COVID-19 spread in Lebanon February 8-21,2021
Omar El Deeb, Maya Jalloul
10.1101/2021.02.09.21251447 — Posted: 2021-02-12
Explaining COVID-19 Outbreaks with Reactive SEIRD Models
Kunal Menda, Lucas Laird, Mykel J. Kochenderfer, Rajmonda S. Caceres
10.1101/2021.02.09.21251440 — Posted: 2021-02-12

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).